Simply Wall St.3d agobullish
Bristol Myers Squibb (BMY) Wins FDA Approval, Is The Rally Already Priced In?News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3127last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.86d agobullish
Bristol Myers Squibb (BMY) Wins FDA Approval, Is The Stock Fully Priced?BioPharma Dive86d agobullish
Bristol Myers wins ‘milestone’ FDA approval of myeloma drug acquired from CelgeneInsider Monkey89d agobullish
AstraZeneca PLC (AZN) vs. Bristol-Myers Squibb Company (BMY): Wall Street Doesn’t Buy This Merger Talk24/7 Wall St.89d agobullish
Legend Biotech Gains 6% on Q2 Earnings Beat as Adjusted EPS Doubles ConsensusInvestopedia97d agobullish
Bristol Myers Squibb Stock Jumps on Reported Merger Talks With AstraZenecaSimply Wall St.100d agobullish
Bristol Myers Squibb (BMY) Earnings Beat And Higher Outlook Put Valuation Back In FocusGuruFocus.com101d agobullish
Bristol-Myers Squibb Co (BMY) (Q2 2026) Earnings Call Highlights: Growth Portfolio Surges 14%, ...InvestorsHub101d agobullish
Bristol Myers Squibb Lifts Full-Year Guidance After Strong Second-Quarter Earnings BeatInvesting.com101d agobullish
Bristol-Myers Squibb raises annual outlook as Q2 tops estimates; shares upReuters111d agobullish
Bristol Myers buys Nvidia's latest AI computing system for drug researchBloomberg137d agobullish
A $30 Billion Cancer Breakthrough Is Under Threat From Global ConflictsGuruFocus.com172d agobullish
BioArctic AB (BRCTF) Q1 2026 Earnings Call Highlights: Strong Sales and Strategic Partnerships ...